The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Amicus Therapeutics Inc shares valued at $3,940 were purchased by BRADLEY CAMPBELL on Feb 19 ’25. At $9.85 per share, BRADLEY CAMPBELL acquired 400 shares.
Also, Campbell Bradley L sold 7,500 shares, netting a total of over 75,124 in proceeds. Following the sale of shares at $10.02 each, the insider now holds 886,654 shares.
Before that, BRADLEY CAMPBELL had added 7,500 shares to its account. In a trade valued at $74,850, the Director bought Amicus Therapeutics Inc shares for $9.98 each.
As published in a research note from Morgan Stanley on December 13, 2024, Amicus Therapeutics Inc [FOLD] has been rated down from an Overweight to an Equal-weight and the price target has been revised to $12 from $17. Analysts at Jefferies started covering the stock with ‘”a Buy”‘ outlook in a report released in early September. As of May 30, 2024, Wells Fargo has initiated its “an Overweight” rating for FOLD. Earlier on May 14, 2024, Guggenheim upgraded its rating. Their new recommendation was “a Buy” for FOLD stock which previously was a “a Neutral”.
Analyzing FOLD Stock Performance
During the last five days, there has been a drop of approximately -0.10%. Over the course of the year, Amicus Therapeutics Inc shares have jumped approximately 1.49%. Shares of the company reached a 52-week high of $10.00 on 02/19/25 and a 52-week low of $8.78 on 01/13/25. A 50-day SMA is recorded $9.62, while a 200-day SMA reached $10.32. Nevertheless, trading volume fell to 4.44 million shares from 2.49 million shares the previous day.
Support And Resistance Levels for Amicus Therapeutics Inc (FOLD)
According to the 24-hour chart, there is a support level at 9.09, which, if violated, would cause prices to drop to 8.61. In the upper region, resistance lies at 10.02. The next price resistance is at 10.47. RSI (Relative Strength Index) is 46.92 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.05, which suggests the price will decrease in the coming days. Percent R is at 47.32%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
